Home/Filings/4/0001482981-25-000120
4//SEC Filing

Prior Jane 4

Accession 0001482981-25-000120

CIK 0001482981other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 6:06 PM ET

Size

18.6 KB

Accession

0001482981-25-000120

Insider Transaction Report

Form 4
Period: 2025-07-01
Prior Jane
Chief Marketing Officer
Transactions
  • Sale

    Common Stock

    2025-07-01$37.07/sh10,000$370,701134,188 total
  • Exercise/Conversion

    Common Stock

    2025-07-01$10.18/sh+10,000$101,780144,188 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-07-0110,00053,750 total
    Exercise: $10.18Exp: 2030-02-10Common Stock (10,000 underlying)
Holdings
  • Non-Qualified Stock Option (right to buy)

    Exercise: $10.18Exp: 2029-12-16Common Stock (3,675 underlying)
    3,675
  • Non-Qualified Stock Option (right to buy)

    Exercise: $10.18Exp: 2031-01-11Common Stock (27,300 underlying)
    27,300
  • Non-Qualified Stock Option (right to buy)

    Exercise: $15.00Exp: 2031-10-21Common Stock (45,605 underlying)
    45,605
  • Non-Qualified Stock Option (right to buy)

    Exercise: $15.36Exp: 2032-08-15Common Stock (42,980 underlying)
    42,980
  • Non-Qualified Stock Option (right to buy)

    Exercise: $26.18Exp: 2034-03-04Common Stock (8,746 underlying)
    8,746
  • Non-Qualified Stock Option (right to buy)

    Exercise: $33.36Exp: 2035-03-04Common Stock (13,218 underlying)
    13,218
  • Non-Qualified Stock Option (right to buy)

    Exercise: $16.91Exp: 2033-03-10Common Stock (14,205 underlying)
    14,205
Footnotes (10)
  • [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  • [F10]The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.24, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]The stock option is fully vested and currently exercisable.
  • [F4]The stock option is fully vested and currently exercisable.
  • [F5]The stock option is fully vested and currently exercisable.
  • [F6]The stock option vests in four equal annual installments beginning on November 27, 2022.
  • [F7]The stock option vests in three equal annual installments beginning on August 15, 2025.
  • [F8]The stock option vests in four equal annual installments beginning on March 10, 2024.
  • [F9]The stock option vests in four equal annual installments beginning on March 4, 2025.

Issuer

Vita Coco Company, Inc.

CIK 0001482981

Entity typeother

Related Parties

1
  • filerCIK 0001886154

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:06 PM ET
Size
18.6 KB